The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
Lipid metabolism in cancer progression and therapeutic strategies
Open accessAbstract
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy producers, signaling molecules, and source material for the biogenesis of cell membranes. The enhanced synthesis, storage, and uptake of lipids contribute to cancer progression. The rewiring of lipid metabolism in cancer has been linked to the activation of oncogenic signaling pathways and cross talk with the tumor microenvironment. The resulting activity favors the survival and proliferation of tumor cells in the harsh conditions within the tumor. Lipid metabolism also plays a vital role in tumor immunogenicity via effects on the function of the noncancer cells within the tumor microenvironment, especially immune‐associated cells. Targeting altered lipid metabolism pathways has shown potential as a promising anticancer therapy. Here, we review recent evidence implicating the contribution of lipid metabolic reprogramming in cancer to cancer progression, and discuss the molecular mechanisms underlying lipid metabolism rewiring in cancer, and potential therapeutic strategies directed toward lipid metabolism in cancer. This review sheds new light to fully understanding of the role of lipid metabolic reprogramming in the context of cancer and provides valuable clues on therapeutic strategies targeting lipid metabolism in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–324 of 324
Vaquero, J., Ho-Bouldoires, T. H. N., Clapéron, A., & Fouassier, L. (2017) · Oncogene · doi:10.1038/onc.2016.462 · Cited by 110
Huang, G.-M., Jiang, Q., Cai, C., Qu, M., & Shen, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.036 · Cited by 109
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
Aylon, Y., Gershoni, A., Rotkopf, R., Biton, I. E., Porat, Z., Koh, A. P., Sun, X., Lee, Y., Fiel, M.-I., Hoshida, Y., et al. (2016) · European Journal of Cancer · doi:10.1016/s0959-8049(16)61580-0 · Cited by 109
Metabolic reprogramming of the tumour microenvironment
Xing, Y., Zhao, S., Zhou, B. P., & Mi, J. (2015) · The FEBS Journal · doi:10.1111/febs.13402 · Cited by 108
Chen, W., Jin, X., Wang, M., Liu, D., Luo, Q. F., Tian, H., Cai, L., Meng, L., Bi, R., Wang, L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131596 · Cited by 106
Rosa, R., Marciano, R., Malapelle, U., Formisano, L., Nappi, L., D’Amato, C., D'Amato, V., Damiano, V., Marfè, G., Vecchio, S. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1050 · Cited by 104
Zaytseva, Y. Y., Elliott, V. A., Rychahou, P., Mustain, W. C., Kim, J. T., Valentino, J., Gao, T., O’Connor, K. L., Neltner, J. M., Lee, E. Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu042 · Cited by 104
Lee, S. S.-Y., Li, J., tai, J. N., Ratliff, T. L., Park, K., & Cheng, J. (2015) · ACS Nano · doi:10.1021/nn504025a · Cited by 103
Self-citationRelat, J., Blancafort, A., Oliveras, G., Cufí, S., Haro, D., Marrero, P., & Puig, T. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-280 · Cited by 103
Lewis, J. A., Scott, S. A., Lavieri, R. R., Buck, J. R., Selvy, P. E., Stoops, S. L., Armstrong, M. D., Brown, H. A., & Lindsley, C. W. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.057 · Cited by 102
Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice
Bi, P., Yue, F., Karki, A., Castro, B., Wirbisky, S. E., Wang, C., Durkes, A., Elzey, B. D., ANDRISANI, O. M., Bidwell, C. A., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160157 · Cited by 100
Luo, J., Hong, Y. K., Lü, Y., Qiu, S., Chaganty, B. K. R., Zhang, L., Wang, X., Li, Q., & Fan, Z. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.020 · Cited by 100
Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
Kimbung, S., Chang, C., Bendahl, P., Dubois, L. G., Thompson, J. W., McDonnell, D. P., & Borgquist, S. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0533 · Cited by 100
Statin Use After Diagnosis of Colon Cancer and Patient Survival
Voorneveld, P. W., Reimers, M. S., Bastiaannet, E., Jacobs, R. J., van Eijk, R., Zanders, M. M. J., Herings, R. M. C., van Herk‐Sukel, M. P. P., Kodach, L. L., van Wezel, T., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.011 · Cited by 100
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Sanfilippo, K. M., Keller, J., Gage, B. F., Luo, S., Wang, T., Moskowitz, G., Gumbel, J. H., Blue, B. J., O’Brian, K., & Carson, K. R. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.3482 · Cited by 99
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
Flaig, T. W., Salzmann‐Sullivan, M., Su, L., Zhang, Z., Joshi, M., Gijón, M. A., Kim, J., Arcaroli, J. J., van Bokhoven, A., Lucia, M. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17359 · Cited by 98
Venant, H., Rahmaniyan, M., Jones, E. E., Lü, P., Lilly, M. B., Garrett-Mayer, E. S., Drake, R. R., Kraveka, J. M., Smith, C. D., & Voelkel‐Johnson, C. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0279 · Cited by 97
Galdieri, L. C., Gatla, H. R., Vancurova, I., & Vančura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.742247 · Cited by 96
Targeting colorectal cancer cells by a novel sphingosine kinase 1 inhibitor PF-543
Ju, T.-F., Gao, D., & Fang, Z.-Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.053 · Cited by 94
Li, T., Zhang, Q., Jiang, Y., Yu, J., Hu, Y., Mou, T., Chen, G., & Li, G. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1069936 · Cited by 94
Liu, P.-P., Liu, J., Jiang, W.-Q., Carew, J. S., Ogasawara, M. A., Pelicano, H., Croce, C. M., Estrov, Z., Xu, R., Keating, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.103 · Cited by 94
Sun, H., Yang, W., Tian, Y., Zeng, X., Zhou, J., Mok, M. T. S., Tang, W., Feng, Y., Xu, L., Chan, A. W. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07402-8 · Cited by 94
Grube, S., Dünisch, P., Freitag, D., Klausnitzer, M., Sakr, Y., Walter, J., Kalff, R., & Ewald, C. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1452-z · Cited by 93
Lee, H. J., Li, J., Vickman, R. E., Li, J., Liu, R. R., Durkes, A. C., Elzey, B. D., Yue, S., Liu, X., Ratliff, T. L., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0665 · Cited by 93
Self-citationMechanisms of Ceramide-Dependent Cancer Cell Death
Nganga, R., Oleinik, N. V., & Öğretmen, B. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.04.007 · Cited by 93
Lopes‐Coelho, F., André, S., Félix, A., & Serpa, J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.031 · Cited by 91
Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
Dorotea, D., Koya, D., & Ha, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00265 · Cited by 91
Ceramide species are elevated in human breast cancer and are associated with less aggressiveness
Moro, K., Kawaguchi, T., Tsuchida, J., Gabriel, E. M., Qi, Q., Yan, L., Wakai, T., Takabe, K., & Nagahashi, M. (2018) · Oncotarget · doi:10.18632/oncotarget.24903 · Cited by 90
Li, G., Li, M., Hu, J., Lei, R., Xiong, H., Ji, H., Yin, H., Wei, Q., & Hu, G. (2016) · Oncogene · doi:10.1038/onc.2016.265 · Cited by 87
Oxysterols and nuclear receptors
Ma, L., & Nelson, E. R. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.016 · Cited by 87
José, C., Hébert-Chatelain, É., Bellancé, N., Larendra, A., Melser, S., Nouette‐Gaulain, K., & Rossignol, R. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.12.002 · Cited by 86
Cathcart, M., Lysaght, J., & Pidgeon, G. P. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9324-x · Cited by 86
Lipid Metabolism Fuels Cancer’s Spread
Li, Z., & Kang, Y. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.01.016 · Cited by 86
Waller, D. D., Park, J., & Tsantrizos, Y. S. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1568964 · Cited by 86
Application of metabolomics in the diagnosis of breast cancer: a systematic review
Yang, L., Wang, Y., Cai, H., Wang, S., Shen, Y., & Ke, C. (2020) · Journal of Cancer · doi:10.7150/jca.37604 · Cited by 86
Ceramide Kinase Promotes Tumor Cell Survival and Mammary Tumor Recurrence
Payne, A. W., Pant, D. K., Pan, T.-C., & Chodosh, L. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1292 · Cited by 85
Alba‐Castellón, L., Olivera‐Salguero, R., Mestre‐Farrera, A., Peña, R., Herrera, M., Bonilla, F., Casal, J. I., Baulida, J., Peña, C., & de Herreros, A. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0176 · Cited by 83
Yang, D., Li, Y., Xing, L., Tan, Y., Sun, J., Zeng, B., Xiang, T., Tan, J., Ren, G., & Yang, D. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0221-6 · Cited by 83
Wu, G., Wang, Q., Xu, Y., Li, J., Zhang, H., Qi, G., & Xia, Q. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1654-6 · Cited by 83
Self-citationHe, Z., Li, Z., Zhang, X., Yin, K., Wang, W., Xu, Z., Li, B., Zhang, L., Xu, J., Sun, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0564-3 · Cited by 82
Qian, X., Gu, L., Ning, H., Zhang, Y., Hsueh, E. C., Fu, M., Hu, X., Wei, L., Hoft, D. F., & Liu, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203141 · Cited by 81
Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner
Shao, W., Machamer, C. E., & Espenshade, P. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069583 · Cited by 79
Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Teoh, S. T., & Lunt, S. Y. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1406 · Cited by 79
Role of cholesterol homeostasis and its efflux pathways in cancer progression
Sharma, B., & Agnihotri, N. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105377 · Cited by 79
Yang, Y., Jan, Y., Liu, Y., Yang, C., Su, C., Chang, Y., Lai, T., Chiou, J., Tsai, H., Lu, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0714oc · Cited by 77
Lecarpentier, Y., CLAES, V. A., Vallée, A., & Hébert, J. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0144-7 · Cited by 77
Kock, A., Larsson, K., Bergqvist, F., Eißler, N., Elfman, L. H. M., Raouf, J., Korotkova, M., Johnsen, J. I., Jakobsson, P., & Kogner, P. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.008 · Cited by 77
Lee, J., Sul, J. Y., Park, J. B., Lee, M. S., Cha, E. Y., Song, I. S., Kim, J. R., & Chang, E. S. (2012) · Phytotherapy Research · doi:10.1002/ptr.4778 · Cited by 75
MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice
Cheng, L., Zhu, Y., Han, H., Zhang, Q., Cui, K., Shen, H., Zhang, J., Yan, J., Prochownik, E. V., & Li, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.309 · Cited by 75
Lala, P. K., Nandi, P., & Majumder, M. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9734-0 · Cited by 75
Horiguchi, A., Asano, T., Asano, T., Ito, K., Sumitomo, M., & Hayakawa, M. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.03.186 · Cited by 73
Li, J., Qu, X., Tian, J., Zhang, J., & Cheng, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193318 · Cited by 72
Self-citationBarajas, J. M., Reyes, R., Guerrero, M. J., Jacob, S. T., Motiwala, T., & Ghoshal, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-27358-5 · Cited by 72
Maione, F., Oliaro‐Bosso, S., Meda, C., Nicolantonio, F. D., Bussolino, F., Balliano, G., Viola, F., & Giraudo, E. (2015) · Scientific Reports · doi:10.1038/srep09054 · Cited by 71
Zhu, Q., Hao, Y., Liu, M.-Z., Yue, J., Ni, J., Yuan, B., & Feng, Y. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.07.100 · Cited by 70
TOFA suppresses ovarian cancer cell growth in vitro and in vivo
Li, S., QIU, L., Wu, B., Shen, H., Zhu, J., Zhou, L., Gu, L., & Di, W. J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1505 · Cited by 70
Lucaciu, A., Brunkhorst, R., Pfeilschifter, J. M., Pfeilschifter, W., & Subburayalu, J. (2020) · Cells · doi:10.3390/cells9061515 · Cited by 70
Pastukhov, O., Schwalm, S. A., Zangemeister‐Wittke, U., Fabbro, D., Bornancin, F., Japtok, L., Kleuser, B., Pfeilschifter, J. M., & Huwiler, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12886 · Cited by 69
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development
Soncini, M., Corna, G., Moresco, M. A., Coltella, N., Restuccia, U., Maggioni, D., Raccosta, L., Lin, C., Invernizzi, F., Crocchiolo, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613332113 · Cited by 69
Ebenezer, D. L., Fu, P., Suryadevara, V., Zhao, Y., & Natarajan, V. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.09.007 · Cited by 68
Self-citationShu, Z., Gao, Y., Zhang, G., Zhou, Y., Cao, J., Wan, D., Zhu, X., & Xiong, W. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14262 · Cited by 67
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
Colombo, M., Mirandola, L., Chiriva‐Internati, M., Basile, A., Locati, M., Lesma, E. A., Chiaramonte, R., & Platonova, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01823 · Cited by 66
Kuang, Y., Li, X., Liu, X., Wei, L., Chen, X., Liu, J., Zhuang, T., Pi, J., Wang, Y., Zhu, C., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa046 · Cited by 66
Self-citationThe effect of altered sphingolipid acyl chain length on various disease models
Park, W., & Park, J. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0310 · Cited by 65
STAT3: The art of multi-tasking of metabolic and immune functions in obesity
Hu, W., Lv, J., Han, M., Yang, Z. P., Li, T. X., Jiang, S., & Yang, Y. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.04.002 · Cited by 64
Target identification reveals lanosterol synthase as a vulnerability in glioma
Phillips, R. E., Yang, Y., Smith, R. C., Thompson, B. M., Yamasaki, T., Soto‐Feliciano, Y. M., Funato, K., Liang, Y., García‐Bermúdez, J., Wang, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820989116 · Cited by 62
27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer
Marwarha, G., Raza, S., Hammer, K. D. P., & Ghribi, O. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.05.012 · Cited by 61
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
Pan, J., Zhang, Q., Palen, K. A., Wang, L., Qiao, L., Johnson, B. D., Sei, S., Shoemaker, R. H., Lubet, R. A., Wang, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.044 · Cited by 61
Yu, C., Niu, X., Du, Y., Chen, Y., Liu, X., Xu, L., Iwakura, Y., Ma, X., Li, Y., Yao, Z., et al. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02445-2 · Cited by 61
Tsuchida, J., Nagahashi, M., Nakajima, M., Moro, K., Tatsuda, K., Ramanathan, R., Takabe, K., & Wakai, T. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.06.022 · Cited by 60
Wang, J., Zhang, L., Kang, D., Yang, D., & Tang, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.7279 · Cited by 60
Pal, S. K., Drabkin, H. A., Reeves, J. A., Hainsworth, J. D., Hazel, S. E., Paggiarino, D. A., Wojciak, J., Woodnutt, G., & Bhatt, R. S. (2016) · Cancer · doi:10.1002/cncr.30393 · Cited by 59
Lei, J., Wang, H., Zhu, D., Wan, Y., & Yin, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29358 · Cited by 59
Wang, H., Lu, J. L., Edmunds, L. R., Kulkarni, S., Dolezal, J. M., Tao, J., Ranganathan, S., Jackson, L. E., Fromherz, M., Beer–Stolz, D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754218 · Cited by 58
Guseva, N. V., Rokhlin, O. W., Glover, R. A., & Cohen, M. B. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.1.15721 · Cited by 57
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Xu, Y. (2019) · Cancers · doi:10.3390/cancers11101523 · Cited by 57
Leclerc, J., Garandeau, D., Pandiani, C., Gaudel, C., Bille, K., Nottet, N., Garcia, V., Colosetti, P., Pagnotta, S., Bahadoran, P., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0500-0 · Cited by 53
Zhou, Y., Little, P. J., Ta, H. T., Xu, S., & Kamato, D. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107404 · Cited by 53
Kimura, Y., & Sumiyoshi, M. (2007) · Nutrition and Cancer · doi:10.1080/01635580701499537 · Cited by 51
PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma
Buhmeida, A. S., Bendardaf, R., Hilska, M., Laine, J., Collan, Y. U., Laato, M. K., Syrjänen, K. J., & Pyrhönen, S. O. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn783 · Cited by 51
Statins Do Not Protect Against Cancer: Quite the Opposite
Ravnskov, U., ROSCH, P. J., & McCully, K. S. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.9564 · Cited by 51
Lu, C., Ma, J., & Cai, D. (2017) · Tumor Biology · doi:10.1177/1010428317697574 · Cited by 51
Yiew, N. K. H., Chatterjee, T. K., Tang, Y., Pellenberg, R., Stansfield, B. K., Bagi, Z. A., Fulton, D. J., Stepp, D. W., Chen, W., Patel, V. S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.758078 · Cited by 49
Nagahashi, M., Yamada, A., Miyazaki, H., Allegood, J. C., Tsuchida, J., Aoyagi, T., Huang, W., Terracina, K. P., Adams, B. J., Rashid, O. M., et al. (2016) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-016-9354-7 · Cited by 48
Lanterna, C., Musumeci, A., Raccosta, L., Corna, G., Moresco, M. A., Maggioni, D., Fontana, R., Doglioni, C., Bordignon, C., Traversari, C., et al. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1884-8 · Cited by 48
Bastos, D., Paupert, J., Maillard, C., Seguin, F., Carvalho, M. A., Agostini, M., Coletta, R., Noël, A., & Graner, E. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.125 · Cited by 48
Gray, R. T., Loughrey, M. B., Bankhead, P., Cardwell, C. R., McQuaid, S., O'Neill, R. F., Arthur, K., Bingham, V., McGready, C., Gavin, A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.139 · Cited by 47
Crous-Masó, J., Palomeras, S., Relat, J., Camó, C., Martínez‐Garza, Ú., Planas, M., Feliu, L., & Puig, T. (2018) · Molecules · doi:10.3390/molecules23051160 · Cited by 47
Zhang, X., Wu, J., Wu, C., Chen, W., Lin, R., Zhou, Y., & Huang, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.036 · Cited by 46
Self-citationXie, H., Heier, C., Kien, B., Vesely, P., Tang, Z.-Y., Sexl, V., Schoiswohl, G., Striessnig-Bina, I., Hoefler, G., Zechner, R., et al. (2020) · Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158737 · Cited by 46
Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth
Ren, X.-R., Wang, J., Osada, T., Mook, R. A., Morse, M. A., Barak, L. S., Lyerly, H. K., & Chen, W. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0528-9 · Cited by 45
Leukotriene B4 Creates a Favorable Microenvironment for Murine Melanoma Growth
Bachi, A. L. L., Kim, F. J. K., Nonogaki, S., Carneiro, C. R. W., Lopes, J. D., Jasiulionis, M. G., & Correa, M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0038 · Cited by 44
Roy, J., Dibaeinia, P., Fan, T. M., Sinha, S., & Das, A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088559 · Cited by 43
Development of a Decision Aid for Genital Gender-Affirming Surgery in Transmen
Özer, M., Pigot, G. L. S., Bouman, M., van de Grift, T. C., Elfering, L., van Mello, N. M., Al-Itejawi, H. H. M., Buncamper, M. E., & Mullender, M. G. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.04.644 · Cited by 42
Belorusova, A. Y., Evertsson, E., Hovdal, D., Sandmark, J., Bratt, E., Maxvall, I., Schulman, I. G., Åkerblad, P., & Lindstedt, E. (2019) · Communications Biology · doi:10.1038/s42003-019-0675-0 · Cited by 42
Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapy
Tang, X., Benesch, M. G. K., & Brindley, D. N. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158716 · Cited by 41
Shim, S. H., Sur, S., Steele, R., Albert, C. J., Huang, C., Ford, D. A., & Ray, R. B. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22882 · Cited by 40
Kanayama, T., Arito, M., So, K., Hachimura, S., Inoue, J., & Sato, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700270200 · Cited by 39
Jain, P., Nattakom, M., Holowka, D., Wang, D. H., Brenna, J. T., Ku, A. T., Nguyen, H., Ibrahim, S. F., & Tumbar, T. (2018) · Stem Cells · doi:10.1002/stem.2868 · Cited by 39
Ceramide and Sphingosine 1-Phosphate in Liver Diseases.
Park, W., Song, J.-H., Kim, G., & Park, T. (2020) · PubMed Central · doi:10.14348/molcells.2020.0054 · Cited by 39
Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biology
Lidgerwood, G. E., Pitson, S. M., Bonder, C. S., & Pébay, A. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.09.001 · Cited by 38
Li, C., Fang, F., Chen, Y., Liu, T., Chan, T., Yu, S.-C., Chen, L., & Huang, H. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2770 · Cited by 37
Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein
Rao, E., Singh, P., Zhai, X., Li, Y., Zhu, G., Zhang, Y., Hao, J., Chi, Y., Brown, R. E., Cleary, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3485 · Cited by 36
Baan, B., Dihal, A. A., Hoff, E., Bos, C. L., Voorneveld, P. W., Koelink, P. J., Wildenberg, M. E., Muncan, V., Heijmans, J., Verspaget, H. W., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-301626 · Cited by 35
Ray, U., Roy, S. S., & Chowdhury, S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000458744 · Cited by 35
Nanjappa, V., Renuse, S., Sathe, G. J., Raja, R., Syed, N., Radhakrishnan, A., Subbannayya, T., Patil, A. H., Marimuthu, A., Sahasrabuddhe, N. A., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1078022 · Cited by 34
Sato, Y., Tsuyama, T., Sato, C., Karim, M. F., Yoshizawa, T., Inoue, M., & Yamagata, K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767574 · Cited by 34
García, M. R., Foretz, M., Viollet, B., Prieto, A., Fraga, M., García‐Caballero, T., Costoya, J. A., & Señarís, R. M. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.014 · Cited by 32
Halama, A., Guerrouahen, B. S., Pasquier, J., Satheesh, N. J., Suhre, K., & Rafii, A. (2017) · Scientific Reports · doi:10.1038/srep39999 · Cited by 32
Göttgens, E., van den Heuvel, C. N. A. M., de Jong, M. C., Kaanders, J. H. A. M., Leenders, W. P. J., Ansems, M., Bussink, J., & Span, P. N. (2019) · Cancers · doi:10.3390/cancers11121971 · Cited by 32
Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma
Li, M.-H., Swenson, R. E., Harel, M., Jana, S., Stolarzewicz, E., Hla, T., Shapiro, L. H., & Ferrer, F. A. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224519 · Cited by 29
Ono, A., Sano, O., Kazetani, K., Muraki, T., Imamura, K., Sumi, H., Matsui, J., & Iwata, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181243 · Cited by 26
He, D., Sun, X., Yang, H., Li, X., & Yang, D. (2018) · Journal of Cancer · doi:10.7150/jca.26374 · Cited by 26
Liu, J., Hao, W., Hsu, Y.-P., Sung, L., Kao, P., Lin, C., Wu, A. T. H., Yuan, K. S., & Wu, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11263 · Cited by 25
Nishizawa, S., Sumi, H., Satoh, Y., Yamamoto, Y., Kitazawa, S., Honda, K., Araki, H., Kakoi, K., Imamura, K., Sasaki, M., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.064 · Cited by 25
Li, Z., Kabir, I., Jiang, H., Zhou, H., Libien, J. M., Zeng, J., Stanek, A., Ou, P., Li, K. R., Zhang, S., et al. (2016) · Hepatology · doi:10.1002/hep.28845 · Cited by 24
The cell biology behind the oncogenic PIP3 lipids
Carrera, A. C., & Anderson, R. (2019) · Journal of Cell Science · doi:10.1242/jcs.228395 · Cited by 23
Yang, P., Hong, Y.-H., Hsu, K., & Liu, T. (2019) · PubMed · Cited by 22
Fatty Acids Corrupt Neutrophils in Cancer
Wellenstein, M. D., & de Visser, K. E. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.007 · Cited by 21
Bahrambeigi, S., Molaparast, M., Sohrabi, F., Seifi, L., Faraji, A., Fani, S., & Shafiei‐Irannejad, V. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.01.006 · Cited by 21
Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?
Wang, A., Wakelee, H. A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. E., & Stefanick, M. L. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0625-y · Cited by 20
Luo, D., Liu, H., Lin, D., Lian, K., & Ren, H. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0881 · Cited by 18
Fan, T. W. ‐., Higashi, R. M., Chernayavskaya, Y., & Lane, A. N. (2020) · Metabolites · doi:10.3390/metabo10060249 · Cited by 16
Majdop, S., Skornick, Y. G., Avital, S., & Berkovich, L. (2018) · Cellular and Molecular Biology · doi:10.14715/cmb/2018.64.14.14 · Cited by 10
Metadata
- Authors
- Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C., Zhao, Y., Qin, L., & Dong, Q.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2020-12-24
- Volume
- 2
- Issue
- 1
- Pages
- 27-59
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W3118120466
- Cited by
- 393
- References
- 324
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.